Hepcidin is a peptide hormone with both paracrine and endocrine functions that help in maintaining body iron stores.Type 2 diabetes(T2D) is one of the sequelae of excess body iron stores; thus,iron regulatory hormone ...Hepcidin is a peptide hormone with both paracrine and endocrine functions that help in maintaining body iron stores.Type 2 diabetes(T2D) is one of the sequelae of excess body iron stores; thus,iron regulatory hormone hepcidin may have a direct or at least an indirect role in the aetiopathogenesis of T2 D.Both human and animal studies at molecular and genetic levels have attemptedto establish a role for hepcidin in the development of T2 D,and a few epidemiologic studies have also showed a link between hepcidin and T2 D at population level,but the findings are still inconclusive.Recent data have suggested different pathways in which hepcidin could be associated with T2 D with much emphasis on its primary or secondary role in insulin resistance.Some of the suggested pathways are via transcription modulator of hepcidin(STAT3); ferroportin 1 expression on the cells involved in iron transport; transmembrane protease 6 enzyme; and pro-inflammatory cytokines,interleukin(IL)-1,IL-6,tumor necrosis factor-α and IL-10.This review briefly reports the existing evidence on the possible links between hepcidin and T2 D and concludes that more data are needed to confirm or refute hepcidin's role in the development of T2 D.Examining this role could provide a further evidence base for iron in the aetiopathogenesis of T2 D.展开更多
文摘Hepcidin is a peptide hormone with both paracrine and endocrine functions that help in maintaining body iron stores.Type 2 diabetes(T2D) is one of the sequelae of excess body iron stores; thus,iron regulatory hormone hepcidin may have a direct or at least an indirect role in the aetiopathogenesis of T2 D.Both human and animal studies at molecular and genetic levels have attemptedto establish a role for hepcidin in the development of T2 D,and a few epidemiologic studies have also showed a link between hepcidin and T2 D at population level,but the findings are still inconclusive.Recent data have suggested different pathways in which hepcidin could be associated with T2 D with much emphasis on its primary or secondary role in insulin resistance.Some of the suggested pathways are via transcription modulator of hepcidin(STAT3); ferroportin 1 expression on the cells involved in iron transport; transmembrane protease 6 enzyme; and pro-inflammatory cytokines,interleukin(IL)-1,IL-6,tumor necrosis factor-α and IL-10.This review briefly reports the existing evidence on the possible links between hepcidin and T2 D and concludes that more data are needed to confirm or refute hepcidin's role in the development of T2 D.Examining this role could provide a further evidence base for iron in the aetiopathogenesis of T2 D.
文摘目的：探讨2型糖尿病患者血清铁调素（Hepcidin）、铁蛋白（SF）、转铁蛋白受体（sTfR）和血清铁（SI）的变化与临床意义。方法130例2型糖尿病患者，分为两组，A 组为微量蛋白尿组45例（mAlb30-300 mg／24 h），B 组为正常蛋白尿组85例（mAlb＜30 mg／24 h），另选同期45例健康体检者为对照 C 组。各组均取空腹晨血5 ml 离心取血清检测铁调素，SF，sTfR 和 SI 含量。结果A 组患者血清铁调素和 SF 水平（42.27±32.12 ng／ml，211.6±107.2 ng／ml）均显著高于B 组（26.12±18.36 ng／ml，179.1±109.7 ng／ml；P 均＜0.05）和 C 组（9.47±1.65 ng／ml，84.41±47.10 ng／ml），（P 均＜0.01）；B 组患者铁调素和 SF 水平显著高于 C 组（P 均＜0.01）。各组之间 SI 水平（15.26μmol／L，18.65μmol／L，17.71μmol／L）和 sTfR 水平（1.12μg／L，1.05μg／L，1.16μg／L）差异均无统计学意义（t ＝0.469-1.176，P 均＞0.05）。相关分析显示，2型糖尿病患者铁调素与 SF 呈显著正相关（r＝0.329，P ＜0.05），铁调素与 sTfR，SI 无显著相关性（r＝0.169，P ＞0.05；r＝－0.149，P ＞0.05）。结论2型糖尿病患者体内存在以血清铁调素、SF 增高为主的铁超负荷和铁代谢紊乱，并与尿微量清蛋白的排泄呈正相关。因此，检测血清铁调素和 SF 可作为糖尿病早期肾功能损伤的重要预测因子。
